BCAT1

Branched-chain-amino-acid aminotransferase, cytosolic · P54687 · BCAT1 on Sugi Atlas →

7,455 patent compounds predicted against BCAT1, 3,990 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3240485 SCHEMBL3240485 0.62 20/20
SCHEMBL3240477 SCHEMBL3240477 0.60 20/20
SCHEMBL3264126 SCHEMBL3264126 0.60 20/20
SCHEMBL2841420 SCHEMBL2841420 0.54 20/20
SCHEMBL3237995 SCHEMBL3237995 0.53 20/20
SCHEMBL2833852 SCHEMBL2833852 0.52 20/20
SCHEMBL2841636 SCHEMBL2841636 0.52 20/20
SCHEMBL2833147 SCHEMBL2833147 0.52 20/20
SCHEMBL1574611 SCHEMBL1574611 0.50 20/20
SCHEMBL1574612 SCHEMBL1574612 0.50 20/20
SCHEMBL1574614 SCHEMBL1574614 0.50 20/20
SCHEMBL1573401 SCHEMBL1573401 0.58 19/20
SCHEMBL4572165 SCHEMBL4572165 0.54 19/20
SCHEMBL2832656 SCHEMBL2832656 0.53 19/20
SCHEMBL2832658 SCHEMBL2832658 0.53 19/20
SCHEMBL2832659 SCHEMBL2832659 0.53 19/20
SCHEMBL2841434 SCHEMBL2841434 0.51 19/20
SCHEMBL2841437 SCHEMBL2841437 0.51 19/20
SCHEMBL2841440 SCHEMBL2841440 0.51 19/20
SCHEMBL1573699 SCHEMBL1573699 0.50 19/20

Clinical trials — most relevant to BCAT1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Role of BCAA in Glucose Homeostasis PHASE4UNKNOWN
Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C PHASE3ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA PHASE1/PHASE2WITHDRAWN
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma PHASE2WITHDRAWN
Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects nanCOMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy Subjects nanCOMPLETED
How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses nanRECRUITING
Alternations in Body Composition of Tonsillectomy Patients During the Recovery Period nanUNKNOWN
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy nanUNKNOWN
Leucine Requirements in School-Age Children nanNOT_YET_RECRUITING
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN
Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD Patients nanCOMPLETED
Alternative Substrates in the Critically Ill Subject nanCOMPLETED
Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation nanCOMPLETED
The Effects of Sodium Phenylbutyrate on Circulating Branched Chain Amino Acids nanCOMPLETED
Lysine Requirement of Elderly Men and Women Over 60 Years of Age nanCOMPLETED
Resistance Exercise Program and Branched Chain Amino Acid Supplementation in Heart Failure Patients nanCOMPLETED
Leucine Requirements During Pregnancy nanRECRUITING
Branched Chained Amino Acid Supplement in Patients Undergoing Lower Limb Bone Cancer Curettage for Bone Metastasis nanNOT_YET_RECRUITING
Effect of Increased Physical Activity and Stopping Evening Snacking in Metabolic Health in Youth With Prediabetes nanRECRUITING
Impact of Branched-chain Amino Acids in the Development of Insulin Resistance nanCOMPLETED
Comparison of Different Weight Loss Diets With Different Protein Content nanCOMPLETED
Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis nanUNKNOWN
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Metabolomics and Bariatric Surgery in Patients With Metabolically Unhealthy Obesity nanCOMPLETED
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects nanCOMPLETED
Evaluation of Amino Acids Bioavailability in a Food Product Based on a Vegetable Protein Combination nanCOMPLETED
Determining the Effect of Protein Quality on Post-exercise Anabolism in Active Youth nanUNKNOWN
Effect of Branched-chain Amino Acid Supplementation on Muscle Damage nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a BCAT1 binder may also engage these)

ProteinNameSimilarity
P24288 0.995 P24288 →
Q9GKM4 0.993 Q9GKM4 →
P54690 0.967 P54690 →
Q9M401 0.959 Q9M401 →
K7QHS5 0.956 K7QHS5 →
Q9FYA6 0.956 Q9FYA6 →
O35854 0.954 O35854 →
BCAT2 Branched-chain-amino-acid aminotransferase, mitochondrial 0.951 landscape →
Q5EA40 0.951 Q5EA40 →
O35855 0.948 O35855 →
Q5RFI8 0.948 Q5RFI8 →
P27119 0.945 P27119 →
Q9I8S4 0.945 Q9I8S4 →
Q5REP0 0.945 Q5REP0 →
B4G0F3 0.944 B4G0F3 →
K7QKH1 0.942 K7QKH1 →
Q6AY30 0.942 Q6AY30 →
Q9D020 0.941 Q9D020 →
P27117 0.941 P27117 →
E0CSI1 0.941 E0CSI1 →
Q7SYN4 0.941 Q7SYN4 →
Q3T067 0.941 Q3T067 →
P46416 0.941 P46416 →
Q9M439 0.940 Q9M439 →
Q9H0P0 0.940 Q9H0P0 →
P27118 0.940 P27118 →
PGM2 Phosphopentomutase 0.940 landscape →
P14019 0.939 P14019 →
Q8R127 0.939 Q8R127 →
Q7TSV4 0.939 Q7TSV4 →